DHCR24

UniProt ID: Q15392
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

DHCR24 encodes Delta(24)-sterol reductase (also known as seladin-1), the terminal enzyme in cholesterol biosynthesis that catalyzes the reduction of the delta-24 double bond of sterol intermediates, primarily converting desmosterol to cholesterol. The enzyme is FAD-dependent, requires NADPH as a cofactor, and is localized to the endoplasmic reticulum membrane. DHCR24 also confers neuroprotection against oxidative stress and amyloid-beta toxicity. Mutations in DHCR24 cause desmosterolosis, a rare autosomal recessive disorder of cholesterol biosynthesis characterized by multiple congenital anomalies and elevated desmosterol levels.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005737 cytoplasm
IBA
GO_REF:0000033
REMOVE
Summary: IBA annotation for cytoplasm is incorrect. DHCR24 is an integral ER membrane protein with its catalytic domain oriented toward the cytoplasm [PMID:11007892, PMID:22010141]. The cytoplasmic annotation reflects the cytoplasmic orientation of the catalytic domain rather than true cytoplasmic localization.
Reason: This annotation incorrectly implies cytoplasmic localization when the protein is actually an integral ER membrane protein with a cytoplasmic-facing catalytic domain. The UniProt record and experimental evidence clearly establish ER membrane as the primary localization [PMID:11007892, PMID:22010141].
Supporting Evidence:
PMID:22010141
We showed that full-length DHCR24 is localized to the membrane of ER, whereas the predicted transmembrane (TM) domain-deleted DHCR24 mutation is localized to the cytoplasm. The change of DHCR24 localization suggests that the N-terminal TM domain is essential for the ER membrane targeting of DHCR24.
GO:0008202 steroid metabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for steroid metabolic process is accurate. DHCR24 is a key enzyme in cholesterol biosynthesis, which is part of steroid metabolism. The annotation is at an appropriate level of specificity given that cholesterol is the precursor for all steroid hormones.
Reason: DHCR24 clearly participates in steroid metabolism through its essential role in cholesterol biosynthesis. Cholesterol is both a steroid itself and the precursor for all steroid hormones. The IBA annotation is well-supported by experimental evidence [PMID:11519011].
Supporting Evidence:
PMID:11519011
We identified the human DHCR24 cDNA, by the similarity between the encoded protein and a recently characterized plant enzyme—DWF1/DIM, from Arabidopsis thaliana —catalyzing a different but partially similar reaction in steroid/sterol biosynthesis in plants. Heterologous expression, in the yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that it encodes DHCR24
GO:0000246 Delta24(24-1) sterol reductase activity
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for Delta24(24-1) sterol reductase activity is correct and represents a core molecular function. This term specifically describes the enzymatic activity of DHCR24 in reducing the delta-24 double bond in sterols, which is directly validated by experimental evidence [PMID:11519011].
Reason: This is the core molecular function of DHCR24, experimentally validated through multiple studies. The enzyme specifically catalyzes the reduction of the delta-24 double bond in sterol intermediates, including desmosterol, lanosterol, and zymosterol [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate and is increased twofold by the addition of FAD to the assay
GO:0050614 Delta24-sterol reductase activity
IEA
GO_REF:0000003
ACCEPT
Summary: IEA annotation for Delta24-sterol reductase activity based on EC number mapping. This is essentially the same function as GO:0000246 but with slightly different terminology. Both terms correctly describe the core enzymatic function of DHCR24.
Reason: This annotation accurately describes the enzymatic activity of DHCR24. The term is based on EC:1.3.1.72 mapping which is experimentally validated [PMID:11519011]. This is a duplicate of GO:0000246 with different terminology but both are correct.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0000139 Golgi membrane
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: IEA annotation for Golgi membrane based on UniProt subcellular location vocabulary. DHCR24 is detected in Golgi to a lesser extent than ER, where cholesterol synthesis occurs [PMID:11007892].
Reason: Golgi localization occurs to a minor extent and is not the primary functionally relevant site. The ER membrane is the established primary location for DHCR24 function in cholesterol biosynthesis. UniProt notes both localizations but emphasizes ER [PMID:11007892].
Supporting Evidence:
PMID:11007892
subcellular fractionation and enzyme assays... seladin-1 is predominantly localized within the ER, and to a lesser amount in Golgi complexes
GO:0005789 endoplasmic reticulum membrane
IEA
GO_REF:0000044
ACCEPT
Summary: IEA annotation for endoplasmic reticulum membrane is accurate and represents the primary cellular localization. This is the established site where DHCR24 performs its enzymatic function in cholesterol biosynthesis, confirmed by multiple experimental studies [PMID:11007892, PMID:22010141].
Reason: ER membrane is the correct and primary localization for DHCR24. This is where the enzyme performs its function in cholesterol biosynthesis. Multiple experimental studies confirm this localization [PMID:11007892, PMID:22010141].
Supporting Evidence:
PMID:11007892
seladin-1 is predominantly localized within the ER, and to a lesser amount in Golgi complexes
GO:0006629 lipid metabolic process
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation for lipid metabolic process based on UniProt keyword mapping. This is accurate but very general. More specific terms like cholesterol biosynthetic process (GO:0006695) better describe the function.
Reason: While accurate, this is a very broad parent term. DHCR24 does participate in lipid metabolism through its role in cholesterol biosynthesis. However, more specific child terms provide better functional description.
Supporting Evidence:
PMID:11519011
in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0006694 steroid biosynthetic process
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation for steroid biosynthetic process is accurate. DHCR24 is essential for cholesterol biosynthesis, and cholesterol is both a steroid and the precursor for all steroid hormones.
Reason: DHCR24 directly participates in steroid biosynthesis through its essential role in producing cholesterol, which is a steroid molecule and the precursor for all steroid hormones [PMID:11519011].
Supporting Evidence:
PMID:11519011
desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
GO:0006695 cholesterol biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for cholesterol biosynthetic process is accurate and represents a core function. DHCR24 is the terminal enzyme in cholesterol biosynthesis, converting desmosterol to cholesterol [PMID:11519011].
Reason: This is a core biological process for DHCR24. The enzyme catalyzes the final step in cholesterol biosynthesis, converting desmosterol to cholesterol. This is experimentally validated [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
GO:0008202 steroid metabolic process
IEA
GO_REF:0000120
ACCEPT
Summary: Duplicate IEA annotation for steroid metabolic process (also annotated with IBA evidence). The annotation is accurate as DHCR24 participates in cholesterol/steroid metabolism.
Reason: Duplicate but accurate annotation. DHCR24 participates in steroid metabolism through cholesterol biosynthesis. The IBA version of this annotation was already accepted.
Supporting Evidence:
PMID:11519011
cholesterol-biosynthesis disorder caused by mutations in DHCR24
GO:0008203 cholesterol metabolic process
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for cholesterol metabolic process is accurate. DHCR24 is directly involved in cholesterol metabolism as the terminal enzyme in cholesterol biosynthesis.
Reason: DHCR24 is a key enzyme in cholesterol metabolism, specifically in the biosynthetic pathway. The annotation accurately captures this core function [PMID:11519011].
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0016126 sterol biosynthetic process
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation for sterol biosynthetic process is accurate. DHCR24 is essential for sterol biosynthesis, specifically in the final step of converting sterol intermediates to cholesterol.
Reason: DHCR24 is a key enzyme in sterol biosynthesis, catalyzing the reduction of the delta-24 double bond in various sterol intermediates including desmosterol, lanosterol, and zymosterol [PMID:11519011].
Supporting Evidence:
PMID:11519011
catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0016491 oxidoreductase activity
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation for oxidoreductase activity is accurate but very general. DHCR24 is indeed an oxidoreductase, specifically a FAD-dependent oxidoreductase that uses NADPH. More specific terms like GO:0016628 provide better functional description.
Reason: DHCR24 is a FAD-dependent oxidoreductase that catalyzes redox reactions using NADPH as electron donor. While accurate, more specific child terms better describe the function [PMID:11519011].
Supporting Evidence:
PMID:11519011
member of a recently defined family of flavin adenine dinucleotide (FAD)-dependent oxidoreductases
GO:0050660 flavin adenine dinucleotide binding
IEA
GO_REF:0000002
ACCEPT
Summary: IEA annotation for FAD binding based on InterPro domain mapping. This is accurate as DHCR24 contains a FAD-binding domain and FAD enhances its enzymatic activity [PMID:11519011].
Reason: DHCR24 is a FAD-dependent oxidoreductase with a conserved FAD-binding domain. Addition of FAD increases enzymatic activity twofold, suggesting noncovalent FAD binding [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate and is increased twofold by the addition of FAD to the assay
GO:0071949 FAD binding
IEA
GO_REF:0000002
ACCEPT
Summary: Duplicate IEA annotation for FAD binding (same as GO:0050660). The annotation is accurate as DHCR24 is a FAD-dependent enzyme.
Reason: Duplicate of GO:0050660 but accurate. DHCR24 requires FAD as a cofactor for its oxidoreductase activity [PMID:11519011].
Supporting Evidence:
PMID:11519011
member of a recently defined family of flavin adenine dinucleotide (FAD)-dependent oxidoreductases
GO:0005515 protein binding
IPI
PMID:30021884
Histone Interaction Landscapes Visualized by Crosslinking Ma...
REMOVE
Summary: Generic protein binding annotation from a large-scale crosslinking mass spectrometry study of intact cell nuclei [PMID:30021884]. The WITH field indicates interaction with PGRMC1 (O00264). The DHCR24-PGRMC1 interaction was detected by crosslinking mass spectrometry (both are ER membrane proteins involved in sterol biology), but the generic protein binding term is uninformative.
Reason: Protein binding without specificity is uninformative per curation guidelines. The interaction was detected in a high-throughput crosslinking study and the functional significance of the DHCR24-PGRMC1 interaction is not well characterized.
Supporting Evidence:
PMID:30021884
Here we use crosslinking mass spectrometry (XL-MS) to chart the protein-protein interactions in intact human nuclei.
GO:0005515 protein binding
IPI
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human ce...
REMOVE
Summary: Generic protein binding annotation from OpenCell high-throughput endogenous tagging study [PMID:35271311]. The WITH field indicates interaction with PGRMC1 (O00264). While PGRMC1 is a known sterol-binding ER membrane protein, the generic protein binding term is uninformative per curation guidelines.
Reason: Non-specific protein binding annotation from high-throughput study lacks functional context. The curation guidelines explicitly state to avoid this vague term. A more specific MF term should be used if the interaction is validated.
Supporting Evidence:
PMID:35271311
We combined genome engineering, confocal live-cell imaging, mass spectrometry, and data science to systematically map the localization and interactions of human proteins.
GO:0006695 cholesterol biosynthetic process
TAS
Reactome:R-HSA-191273
ACCEPT
Summary: TAS annotation from Reactome for cholesterol biosynthetic process. This is a core function of DHCR24 as the terminal enzyme in cholesterol biosynthesis.
Reason: DHCR24 is the terminal enzyme in cholesterol biosynthesis. This Reactome annotation accurately captures this core biological process [PMID:11519011].
Supporting Evidence:
PMID:11519011
desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
GO:0033489 cholesterol biosynthetic process via desmosterol
TAS
Reactome:R-HSA-6807047
ACCEPT
Summary: TAS annotation from Reactome for cholesterol biosynthesis via desmosterol. This is the primary pathway where DHCR24 functions, converting desmosterol to cholesterol in the Bloch pathway.
Reason: This specifically describes the Bloch pathway where DHCR24 catalyzes the conversion of desmosterol to cholesterol. This is the primary route and core function of DHCR24 [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
GO:0033490 cholesterol biosynthetic process via lathosterol
TAS
Reactome:R-HSA-6807062
ACCEPT
Summary: TAS annotation from Reactome for cholesterol biosynthesis via lathosterol (Kandutsch-Russell pathway). DHCR24 can act on various sterol intermediates including those in this alternate pathway.
Reason: DHCR24 functions in both the Bloch and Kandutsch-Russell pathways of cholesterol biosynthesis. It can reduce the delta-24 double bond in various sterol intermediates [PMID:25637936].
Supporting Evidence:
PMID:25637936
DHCR24 is positioned not only at the end of the Bloch pathway but also at the gateway of the Kandutsch-Russell pathway... able to act on any of the intermediates in the Bloch pathway to divert them into the Kandutsch-Russell pathway
GO:0007265 Ras protein signal transduction
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation for Ras signaling transferred from orthologs. While DHCR24/seladin-1 mediates response to Ras-induced senescence [PMID:15577914], this is a stress response function rather than core Ras signaling.
Reason: DHCR24/seladin-1 responds to oncogenic Ras stress but is not a core component of Ras signaling. It mediates Ras-induced senescence through p53 interactions [PMID:15577914]. This is a secondary, non-core function.
Supporting Evidence:
PMID:15577914
Seladin-1 (also known as Dhcr24) as a key mediator of Ras-induced senescence. Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus
GO:0008104 intracellular protein localization
IEA
GO_REF:0000107
REMOVE
Summary: IEA annotation for intracellular protein localization from ortholog transfer. This is vague and lacks supporting evidence for DHCR24 having a role in localizing other proteins.
Reason: No evidence that DHCR24 functions in protein localization. This appears to be an over-annotation from ortholog transfer without validation. The primary function is enzymatic in cholesterol biosynthesis.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0008285 negative regulation of cell population proliferation
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation for negative regulation of proliferation. DHCR24/seladin-1 does mediate Ras-induced senescence and suppresses transformation [PMID:15577914], supporting an anti-proliferative role.
Reason: DHCR24/seladin-1 mediates oncogenic stress-induced senescence and suppresses cellular transformation [PMID:15577914]. This is a validated but non-core function distinct from its primary enzymatic role.
Supporting Evidence:
PMID:15577914
Ablation of Seladin-1 causes the bypass of Ras-induced senescence in rodent and human fibroblasts, and allows Ras to transform these cells
GO:0009725 response to hormone
IEA
GO_REF:0000107
REMOVE
Summary: IEA annotation for response to hormone from ortholog transfer. This is too vague without specifying which hormones. Cholesterol biosynthesis is regulated by hormones but this annotation lacks specificity.
Reason: Overly broad annotation without supporting evidence for specific hormone responses by DHCR24. While cholesterol biosynthesis is hormonally regulated, this vague annotation provides no functional insight.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0009888 tissue development
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation for tissue development from ortholog transfer. While DHCR24 mutations cause developmental anomalies in desmosterolosis, this is an indirect effect of cholesterol deficiency.
Reason: DHCR24 deficiency causes developmental defects in desmosterolosis patients [PMID:11519011], but this is secondary to cholesterol deficiency rather than a direct developmental role. Non-core but valid consequence.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
GO:0016125 sterol metabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: IEA annotation for sterol metabolic process is accurate. DHCR24 is directly involved in sterol metabolism through its enzymatic activity on various sterol intermediates.
Reason: DHCR24 directly participates in sterol metabolism by catalyzing the reduction of the delta-24 double bond in multiple sterol intermediates [PMID:11519011].
Supporting Evidence:
PMID:11519011
catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0030539 male genitalia development
IEA
GO_REF:0000107
REMOVE
Summary: IEA annotation for male genitalia development from ortholog transfer. While desmosterolosis can include urogenital anomalies, this is too specific and indirect.
Reason: Over-specific developmental annotation. While desmosterolosis includes congenital anomalies, singling out male genitalia development is not supported as a specific function of DHCR24. This is an indirect effect of cholesterol deficiency.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
GO:0031639 plasminogen activation
IEA
GO_REF:0000107
REMOVE
Summary: IEA annotation for plasminogen activation from ortholog transfer. No evidence supports DHCR24 involvement in plasminogen activation. This is an erroneous transfer.
Reason: No evidence linking DHCR24 to plasminogen activation. This is an incorrect ortholog transfer. DHCR24 functions in cholesterol biosynthesis, not coagulation/fibrinolysis pathways.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0042987 amyloid precursor protein catabolic process
IEA
GO_REF:0000107
REMOVE
Summary: IEA annotation for APP catabolism from ortholog transfer. While DHCR24/seladin-1 protects against amyloid-beta toxicity [PMID:11007892], it does not directly catabolize APP.
Reason: DHCR24/seladin-1 protects against amyloid-beta toxicity but does not catabolize APP. The protective effect is through reducing oxidative stress and caspase activation, not APP processing [PMID:11007892].
Supporting Evidence:
PMID:11007892
Functional expression of seladin-1 in human neuroglioma H4 cells resulted in the inhibition of caspase 3 activation after either Aβ-mediated toxicity or oxidative stress and protected the cells from apoptotic cell death
GO:0043588 skin development
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation for skin development from ortholog transfer. While cholesterol is important for skin barrier function, this is an indirect effect of DHCR24 enzymatic activity.
Reason: Cholesterol biosynthesis is important for skin development and barrier function. DHCR24 deficiency can affect skin, but this is secondary to its enzymatic role. Non-core but valid indirect function.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
GO:0061024 membrane organization
IEA
GO_REF:0000107
REMOVE
Summary: IEA annotation for membrane organization from ortholog transfer. While cholesterol is crucial for membrane structure, DHCR24 does not directly organize membranes.
Reason: DHCR24 produces cholesterol which affects membrane properties, but the enzyme itself does not organize membranes. This is an over-interpretation of its indirect effects through cholesterol production.
Supporting Evidence:
PMID:11519011
enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond of sterol intermediates
GO:0050614 Delta24-sterol reductase activity
EXP
PMID:11519011
Mutations in the 3beta-hydroxysterol Delta24-reductase gene ...
ACCEPT
Summary: Experimental evidence for Delta24-sterol reductase activity from the key paper identifying DHCR24. This is the core molecular function, directly demonstrated through heterologous expression and enzyme activity measurements.
Reason: Direct experimental validation of DHCR24 enzymatic activity. The study used heterologous expression in yeast followed by enzyme activity measurements to confirm Delta24-sterol reductase activity [PMID:11519011].
Supporting Evidence:
PMID:11519011
Heterologous expression, in the yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that it encodes DHCR24
GO:0050614 Delta24-sterol reductase activity
TAS
Reactome:R-HSA-9755937
ACCEPT
Summary: TAS annotation from Reactome for Delta24-sterol reductase activity, specifically for lanosterol reduction. This is a validated core molecular function of DHCR24.
Reason: DHCR24 catalyzes the reduction of the delta-24 double bond in multiple sterols including lanosterol. This Reactome annotation correctly captures this enzymatic activity [PMID:11519011].
Supporting Evidence:
file:human/DHCR24/DHCR24-uniprot.txt
Reaction=lanosterol + NADPH + H(+) = 24,25-dihydrolanosterol + NADP(+)
GO:0000246 Delta24(24-1) sterol reductase activity
IMP
PMID:11519011
Mutations in the 3beta-hydroxysterol Delta24-reductase gene ...
ACCEPT
Summary: IMP evidence for Delta24(24-1) sterol reductase activity from mutant phenotype analysis. Mutations in DHCR24 cause desmosterolosis with accumulation of desmosterol, proving this enzymatic function.
Reason: Mutations in DHCR24 cause desmosterolosis with elevated desmosterol levels, directly demonstrating the enzyme's Delta24-sterol reductase activity through mutant phenotype [PMID:11519011].
Supporting Evidence:
PMID:11519011
Patients with desmosterolosis have elevated levels of the cholesterol precursor desmosterol, in plasma, tissue, and cultured cells; this abnormality suggests a deficiency of the enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24)
GO:0005789 endoplasmic reticulum membrane
NAS
PMID:11007892
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistan...
ACCEPT
Summary: NAS evidence for ER membrane localization from the seladin-1 paper. Subcellular fractionation confirmed predominant ER localization. This is the primary and functionally relevant cellular location.
Reason: Experimental subcellular fractionation demonstrated that seladin-1/DHCR24 is predominantly localized to the ER membrane, where it performs its enzymatic function [PMID:11007892].
Supporting Evidence:
PMID:11007892
subcellular fractionation and enzyme assays... seladin-1 is predominantly localized within the ER, and to a lesser amount in Golgi complexes
GO:0006695 cholesterol biosynthetic process
IMP
PMID:11519011
Mutations in the 3beta-hydroxysterol Delta24-reductase gene ...
ACCEPT
Summary: IMP evidence for cholesterol biosynthetic process from mutant phenotype. DHCR24 mutations cause desmosterolosis with defective cholesterol biosynthesis, proving this core function.
Reason: Mutations in DHCR24 cause desmosterolosis, a cholesterol biosynthesis disorder, directly demonstrating the enzyme's essential role in cholesterol biosynthesis [PMID:11519011].
Supporting Evidence:
PMID:11519011
Our data demonstrate that desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
GO:0033489 cholesterol biosynthetic process via desmosterol
IMP
PMID:11519011
Mutations in the 3beta-hydroxysterol Delta24-reductase gene ...
ACCEPT
Summary: IMP evidence for cholesterol biosynthesis via desmosterol pathway. Patients with DHCR24 mutations accumulate desmosterol, proving this is the enzyme that converts desmosterol to cholesterol.
Reason: DHCR24 deficiency causes desmosterol accumulation, directly demonstrating its role in the desmosterol-to-cholesterol conversion in the Bloch pathway [PMID:11519011].
Supporting Evidence:
PMID:11519011
Patients with desmosterolosis have elevated levels of the cholesterol precursor desmosterol... Conversion of desmosterol to cholesterol by DHCR24
GO:0005515 protein binding
IPI
PMID:25637936
The terminal enzymes of cholesterol synthesis, DHCR24 and DH...
REMOVE
Summary: IPI evidence for protein binding with DHCR7. While this specific DHCR7 interaction is functionally important, the generic "protein binding" term should be avoided per curation guidelines.
Reason: Generic protein binding annotation should be removed even for specific interactions. The functionally relevant DHCR7 interaction and its regulatory effect on enzyme activity is better captured by more specific functional terms.
Supporting Evidence:
PMID:25637936
when the DHCR24 gene is knocked down by siRNA, DHCR7 activity is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity, but only when a functional form of DHCR24 is used
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-196417
ACCEPT
Summary: TAS annotation from Reactome for ER membrane localization. This is the correct primary localization where DHCR24 performs its enzymatic function.
Reason: ER membrane is the established localization for DHCR24 where it catalyzes the conversion of desmosterol to cholesterol [PMID:11007892, PMID:22010141].
Supporting Evidence:
PMID:22010141
The membrane topological analysis of 3β-hydroxysteroid-delta24 reductase (DHCR24) on endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-6807064
ACCEPT
Summary: Another TAS annotation from Reactome for ER membrane. This is a duplicate but correct annotation for the primary cellular localization.
Reason: Duplicate but accurate ER membrane localization annotation from Reactome. Multiple evidence sources confirm this localization [PMID:11007892].
Supporting Evidence:
PMID:11007892
seladin-1 is predominantly localized within the ER
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-9755937
ACCEPT
Summary: Another TAS annotation from Reactome for ER membrane. Multiple Reactome pathways correctly place DHCR24 at the ER membrane.
Reason: Another duplicate but accurate ER membrane annotation. The ER is where DHCR24 performs its enzymatic function in cholesterol biosynthesis [PMID:11007892].
Supporting Evidence:
PMID:11007892
seladin-1 is predominantly localized within the ER
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells.
ACCEPT
Summary: HDA evidence for membrane localization from NK cell proteomics study. This is very general compared to the specific ER membrane localization established by other studies.
Reason: While less specific than ER membrane annotations, this high-throughput data confirms DHCR24 is membrane-associated, consistent with its ER membrane localization [PMID:19946888].
Supporting Evidence:
PMID:19946888
Defining the membrane proteome of NK cells
GO:0016628 oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor
IDA
PMID:11519011
Mutations in the 3beta-hydroxysterol Delta24-reductase gene ...
ACCEPT
Summary: IDA evidence for specific oxidoreductase activity. This accurately describes DHCR24 mechanism - it reduces C-C double bonds (delta-24) using NADPH as electron donor.
Reason: Direct experimental demonstration that DHCR24 is an oxidoreductase acting on CH-CH groups (the delta-24 double bond) with NADPH as acceptor. This is more specific than general oxidoreductase activity [PMID:11519011].
Supporting Evidence:
PMID:11519011
Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
GO:0006695 cholesterol biosynthetic process
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation for cholesterol biosynthetic process based on sequence similarity. This is a duplicate annotation but correctly identifies a core function.
Reason: Sequence similarity-based annotation that correctly identifies DHCR24 role in cholesterol biosynthesis. This is validated by experimental evidence [PMID:11519011].
Supporting Evidence:
PMID:11519011
desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24
GO:0019899 enzyme binding
IPI
PMID:15577914
Regulation of cellular response to oncogenic and oxidative s...
KEEP AS NON CORE
Summary: IPI evidence for enzyme binding from the seladin-1 stress response paper. DHCR24/seladin-1 binds to Mdm2 (an E3 ubiquitin ligase) to regulate p53. This is a non-core stress response function.
Reason: DHCR24/seladin-1 binds the E3 ubiquitin ligase Mdm2 during stress response, affecting p53 regulation. This is a validated but non-core function distinct from its primary enzymatic role [PMID:15577914].
Supporting Evidence:
PMID:15577914
Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53... Additionally, Seladin-1 associates with Mdm2 independently of p53
GO:0043588 skin development
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation for skin development based on sequence similarity. While cholesterol is important for skin, this is an indirect effect of DHCR24 enzymatic function.
Reason: Cholesterol biosynthesis impacts skin development and barrier function. DHCR24 deficiency can cause skin abnormalities, but this is secondary to its enzymatic role. Non-core indirect function.
Supporting Evidence:
PMID:11519011
Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies
GO:0005634 nucleus
IDA
PMID:15577914
Regulation of cellular response to oncogenic and oxidative s...
KEEP AS NON CORE
Summary: IDA evidence for nuclear localization from stress response study. DHCR24/seladin-1 translocates to the nucleus during oncogenic and oxidative stress [PMID:15577914], though the primary functional localization is ER membrane.
Reason: DHCR24/seladin-1 can localize to nucleus during stress response to interact with p53/Mdm2, but this is not the primary localization. Main function occurs at ER membrane [PMID:15577914, PMID:11007892].
Supporting Evidence:
PMID:15577914
Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53
GO:0005783 endoplasmic reticulum
IDA
PMID:11007892
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistan...
ACCEPT
Summary: IDA evidence for ER localization from the seladin-1 paper. This is the correct primary localization, though ER membrane (GO:0005789) is more specific.
Reason: Direct experimental evidence for ER localization through subcellular fractionation. The more specific ER membrane term is also annotated [PMID:11007892].
Supporting Evidence:
PMID:11007892
subcellular fractionation and enzyme assays... seladin-1 is predominantly localized within the ER
GO:0009888 tissue development
IMP
PMID:12457401
Desmosterolosis presenting with multiple congenital anomalie...
KEEP AS NON CORE
Summary: IMP evidence for tissue development from a desmosterolosis case report showing developmental delay and anomalies. This is an indirect effect of cholesterol deficiency rather than a direct developmental role.
Reason: DHCR24 deficiency causes developmental anomalies in desmosterolosis due to cholesterol deficiency. This is an indirect consequence rather than a direct developmental function [PMID:12457401].
Supporting Evidence:
PMID:12457401
Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay
GO:0042605 peptide antigen binding
IPI
PMID:15577914
Regulation of cellular response to oncogenic and oxidative s...
REMOVE
Summary: IPI evidence for peptide antigen binding from the seladin-1 stress response study [PMID:15577914]. The WITH field shows UniProtKB:P04637 (p53), indicating the annotation was made based on seladin-1 binding the p53 N-terminus. However, this interaction is protein-protein binding to p53 during stress response, not peptide antigen binding in an immunological sense. The GO term peptide antigen binding (GO:0042605) refers to binding of antigenic peptides for immune presentation, which does not describe the DHCR24-p53 interaction.
Reason: This is a misannotation. PMID:15577914 describes DHCR24/seladin-1 binding to the p53 amino terminus during oncogenic and oxidative stress, displacing Mdm2. This is a protein-protein interaction, not peptide antigen binding in the immunological sense. No MHC or antigen presentation function is described.
Supporting Evidence:
PMID:15577914
Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53, thus resulting in p53 accumulation.

Core Functions

Catalyzes the reduction of the delta-24 double bond in sterol intermediates using NADPH and FAD as cofactors, converting desmosterol to cholesterol as the terminal step of cholesterol biosynthesis

Positively regulates DHCR7 oxidoreductase activity through direct protein interaction, enhancing 7-dehydrocholesterol reductase function in cholesterol biosynthesis

Supporting Evidence:
  • PMID:25637936
    when the DHCR24 gene is knocked down by siRNA, DHCR7 activity is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity

References

Gene Ontology annotation through association of InterPro records with GO terms.
Gene Ontology annotation based on Enzyme Commission mapping
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity.
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.
Combined Automated Annotation using Multiple IEA Methods.
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress.
Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.
Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay.
Regulation of cellular response to oncogenic and oxidative stress by Seladin-1.
Defining the membrane proteome of NK cells.
The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact physically and functionally.
Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei.
OpenCell: Endogenous tagging for the cartography of human cellular organization.
Reactome:R-HSA-191273
Cholesterol biosynthesis
Reactome:R-HSA-196417
Reduction of desmosterol to cholesterol
Reactome:R-HSA-6807047
Cholesterol biosynthesis via desmosterol
Reactome:R-HSA-6807062
Cholesterol biosynthesis via lathosterol
Reactome:R-HSA-6807064
DHCR24 reduces ZYMOL to ZYMSTNL
Reactome:R-HSA-9755937
DHCR24 reduces LAN to 24,25-dhLAN

Suggested Questions for Experts

Q: How does DHCR24 coordinate cholesterol biosynthesis with membrane homeostasis and cellular sterol requirements?

Q: What are the regulatory mechanisms that control DHCR24 expression and activity in response to sterol levels?

Q: How do mutations in DHCR24 lead to desmosterolosis and what are the developmental consequences of altered sterol metabolism?

Q: What determines the subcellular localization of DHCR24 and how does this affect its function in sterol metabolism?

Suggested Experiments

Experiment: Lipidomics analysis to characterize the complete sterol profile in DHCR24-deficient cells and tissues

Experiment: Live-cell imaging using fluorescent sterol analogs to track cholesterol metabolism and membrane distribution in real-time

Experiment: Cryo-EM structure determination of DHCR24 to understand the molecular basis of sterol reduction and enzyme specificity

Experiment: Developmental analysis of DHCR24 mutant model organisms to study the role of cholesterol in embryogenesis and organogenesis

Deep Research

Falcon

(DHCR24-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 26 citations 2026-03-06T03:22:50.611634

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Functional annotation of human DHCR24 (UniProt Q15392)

0) Identity verification (mandatory)

The target is human DHCR24 (UniProt Q15392), encoding Δ(24)-sterol reductase (also called 24-dehydrocholesterol reductase, 3β-hydroxysterol Δ24-reductase, and seladin-1). This identity is consistent across recent reviews and primary studies, including work that explicitly retrieved the sequence from UniProt Q15392 for modeling/inhibitor screening. (fu2024dhcr24intumor pages 1-2, wang2023virtualscreeningof pages 12-13)

Category Key points Evidence
Identity and synonyms Human delta(24)-sterol reductase; gene DHCR24; also known as seladin-1; UniProt Q15392 (fu2024dhcr24intumor pages 12-13, fu2024dhcr24intumor pages 1-2)
Enzymatic reaction and substrates FAD-dependent reduction of the Δ24(25) double bond in sterol intermediates; converts desmosterol to cholesterol (terminal Bloch step) (wang2023virtualscreeningof pages 1-2, bai2022theroleof pages 3-5)
Required cofactors/electron donor Flavin adenine dinucleotide (FAD) cofactor; in vitro conversion strictly dependent on reduced NADPH; activity increased by added FAD (cocciadiferro2024exploitinginsilico pages 1-2, wang2023virtualscreeningof pages 1-2)
Pathway placement Operates in the Bloch pathway (desmosterol → cholesterol) and links to the Kandutsch–Russell route; controls post-lanosterol flux (bai2022theroleof pages 3-5, skubic2024knockoutsofcyp51a1 pages 8-10)
Subcellular localization/topology ER/Golgi-associated single-pass membrane enzyme; N-terminus luminal; C-terminal cytosolic region harbors FAD-binding domain (fu2024dhcr24intumor pages 1-2, fu2024dhcr24intumor pages 12-13)
Notable inhibitors/regulators (quantitative) Irbesartan is a competitive DHCR24 inhibitor (IC50 ≈ 602 nM in vitro); SH-42 reported as potent probe inhibitor (IC50 ≈ 4 nM); U18666A inhibits DHCR24 (wang2023virtualscreeningof pages 1-2, peeples2024chemicalinhibitionof pages 17-18)
Genetic disease: desmosterolosis Autosomal recessive sterol biosynthesis disorder with elevated desmosterol; neurodevelopmental anomalies; recent case validated novel p.M169T variant affecting FAD interactions (cocciadiferro2024exploitinginsilico pages 1-2, fu2024dhcr24intumor pages 12-13)
2023–2024 finding: AD model AAV-mediated hippocampal DHCR24 overexpression in 5xFAD mice increased cholesterol and reversed cognitive impairment and AD-like pathology (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15)
2023–2024 finding: melanoma resistance DHCR24/27HC axis promotes melanoma spheroid growth and vemurafenib resistance; 27-hydroxycholesterol increased by ~41.39% (from 89.784→129.240 ng/mL; p=0.0000751) upon DHCR24 overexpression (wang2024cholesterolneutralizedvemurafenib pages 10-13, wang2024cholesterolneutralizedvemurafenib media 6e0d6af5)
2023–2024 finding: diet-induced brain injury High-fat diet downregulated DHCR24 protein in mouse brain, associated with neuronal apoptosis and ER-stress markers; DHCR24 overexpression rescued cholesterol-loading toxicity in N2a cells (lu2023highfatdiet pages 9-12)

Table: Compact functional-annotation table for human DHCR24 (Q15392), covering identity, reaction, cofactors, pathway position, localization, inhibitors, genetic disease, and recent 2023–2024 model findings with quantitative data. Each entry includes primary evidence citations for rapid reference.

1) Key concepts and current understanding

1.1 Core biochemical function (reaction, substrate specificity, cofactors)

DHCR24 is a flavin adenine dinucleotide (FAD)-dependent oxidoreductase in the distal cholesterol biosynthetic pathway that reduces the Δ24 double bond of sterol intermediates; in the canonical Bloch pathway it catalyzes desmosterol → cholesterol. (wang2023virtualscreeningof pages 1-2, bai2022theroleof pages 3-5)

Biochemical requirements include reduced NADPH (as electron donor) and FAD as cofactor; in vitro desmosterol→cholesterol conversion by DHCR24 is reported as strictly NADPH-dependent and ~2-fold increased by addition of FAD. (cocciadiferro2024exploitinginsilico pages 1-2)

1.2 Pathway position and flux (Bloch vs Kandutsch–Russell)

DHCR24 is positioned at a late step of cholesterol synthesis and is described as acting on sterols in the Bloch arm, with sterol intermediates able to shift between Bloch and Kandutsch–Russell routes (post-lanosterol), making DHCR24 activity a key determinant of sterol intermediate pools (e.g., desmosterol accumulation upon loss/inhibition). (bai2022theroleof pages 3-5, fu2024dhcr24intumor pages 2-3)

1.3 Cellular localization and membrane topology

DHCR24 is a membrane-associated enzyme localized to endoplasmic reticulum (ER) (and described in review sources as present in ER/Golgi-associated membranes), with a single-pass transmembrane segment and a largely cytosolic C-terminal region containing the FAD-binding domain and interaction regions (e.g., reported p53/Mdm2 binding regions in cancer-oriented reviews). (fu2024dhcr24intumor pages 1-2, fu2024dhcr24intumor pages 2-3)

2) Recent developments and latest research (prioritize 2023–2024)

Year Study (first author) Publication (journal) System/model Key finding Quantitative/statistical highlights Potential application/implementation
2023 Wang Molecules HepG2 cells; high-fat-diet (HFD) mice Repurposed DHCR24 inhibitors (incl. irbesartan) competitively inhibit DHCR24 and reduce cholesterol Irbesartan IC50 = 602 nM in immune-complex assay; reduced cellular cholesterol and improved serum lipids in HFD mice (wang2023virtualscreeningof pages 1-2) Cholesterol-lowering strategy; candidate repurposing for patients with hyperlipidemia and comorbidities (wang2023virtualscreeningof pages 1-2)
2023 Zhang Acta Neuropathol Commun 5xFAD Alzheimer’s mice; AAV-DHCR24 hippocampal delivery DHCR24 overexpression raised hippocampal cholesterol and reversed cognitive deficits and AD-like pathology Significant behavioral rescue; reduced amyloid-β; increased filipin cholesterol signal (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15) Gene therapy approach to restore neuronal cholesterol in AD (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15)
2023 Lu Cell Tissue Res HFD mouse brain; N2a neuronal cells HFD downregulated DHCR24 protein via ubiquitination (MDM2); DHCR24 overexpression rescued cholesterol-loading toxicity ER-stress markers (BiP/CHOP) up; DHCR24 protein decreased despite mRNA unchanged; rescue by Ad-DHCR24 (lu2023highfatdiet pages 9-12) Targeting MDM2/DHCR24 axis; neuroprotection under metabolic stress (lu2023highfatdiet pages 9-12)
2024 Wang Cell Mol Life Sci Melanoma (A375/A2058) spheroids; patient datasets DHCR24-driven cholesterol elevates 27-hydroxycholesterol (27HC) to activate Rap1–PI3K/AKT and vemurafenib resistance 27HC ↑41.39% (89.784 → 129.240 ng/mL; p=0.0000751) with DHCR24 overexpression; CYP27A1 inhibition (dafadine-A) attenuated resistance (wang2024cholesterolneutralizedvemurafenib pages 10-13, wang2024cholesterolneutralizedvemurafenib media 6e0d6af5) Target CYP27A1/27HC to overcome BRAF inhibitor resistance (wang2024cholesterolneutralizedvemurafenib pages 10-13, wang2024cholesterolneutralizedvemurafenib media 6e0d6af5)
2024 Skubic iScience HepG2 DHCR24 knockout; sterolomics/transcriptomics Desmosterol accumulation and sterol rewiring alter proliferation and WNT/LEF1 signaling G0+G1 increased to 63% in DHCR24 KO vs 58% native; distinct pathway changes vs CYP51/SC5D KOs (skubic2024knockoutsofcyp51a1 pages 8-10, skubic2024knockoutsofcyp51a1 pages 10-12) Pathway-informed targeting by sterol intermediates; cell-cycle modulation biomarkers (skubic2024knockoutsofcyp51a1 pages 8-10, skubic2024knockoutsofcyp51a1 pages 10-12)
2024 Cocciadiferro Front Genet Desmosterolosis patient (WES; MD sims; biochemical assay) Novel DHCR24 variant p.M169T disrupts FAD interactions; genotype–phenotype expansion In vitro desmosterol→cholesterol conversion strictly NADPH-dependent; +FAD doubles activity; variant validated deleterious (cocciadiferro2024exploitinginsilico pages 1-2) Genetic diagnosis/variant interpretation; counseling and mechanistic insight (cocciadiferro2024exploitinginsilico pages 1-2)
2024 Peeples Biomolecules (review) Chemical inhibition landscape Late-pathway druggability; SH42 probe; amiodarone and other FDA drugs can inhibit DHCR24; desmosterol links to LXR/pro-resolving mediators SH42 highlighted as potent probe; catalog of inhibitors; translational/safety gaps noted (peeples2024chemicalinhibitionof pages 6-7, peeples2024chemicalinhibitionof pages 17-18) Safety pharmacology; probe-led mechanistic and therapeutic development (peeples2024chemicalinhibitionof pages 6-7, peeples2024chemicalinhibitionof pages 17-18)

Table: A concise table of 2023–2024 developments and applications for DHCR24, spanning biochemistry, disease models, genetics, and translational strategies. It includes quantitative metrics (e.g., IC50, 27HC change) and potential implementations, with inline citations to primary sources.

2.1 2024: Human genetics—desmosterolosis genotype–phenotype work

A 2024 study expanded DHCR24-related desmosterolosis by reporting a patient homozygous for DHCR24 p.M169T (c.506T>C) with functional validation and molecular dynamics evidence implicating disrupted interactions in/near the FAD/cofactor interaction network; this strengthens mechanistic interpretation of pathogenic alleles affecting the catalytic core. (cocciadiferro2024exploitinginsilico pages 1-2)

2.2 2023: Chemical biology and inhibitor development/repurposing

A 2023 inhibitor repurposing study identified multiple DrugBank candidates (irbesartan, risperidone, tolvaptan, conivaptan) that lowered cholesterol in HepG2 cells and improved lipid parameters in a mouse hyperlipidemia model; it quantified irbesartan inhibition of DHCR24 with IC50 = 602 nM using an in vitro enzymatic assay. (wang2023virtualscreeningof pages 1-2, wang2023virtualscreeningof pages 12-13)

A 2024 review emphasized the broader “chemical inhibition landscape” of post-lanosterol sterol synthesis and highlighted potent DHCR24 chemical probes (e.g., SH42) and the possibility that numerous FDA-approved medications can inhibit late sterol enzymes (including DHCR24), arguing that sterol pathway inhibition is underappreciated in safety contexts. (peeples2024chemicalinhibitionof pages 6-7, peeples2024chemicalinhibitionof pages 17-18)

2.3 2024: Sterol intermediates as signaling modulators (cell models)

A 2024 iScience study used HepG2 DHCR24 knockout (and other late-pathway KOs) to show that distinct sterol intermediate accumulation states drive distinct regulatory programs and cell-cycle phenotypes; in the DHCR24 KO, the G0+G1 fraction increased to 63% vs 58% in native cells, consistent with slower growth under some conditions and supporting the concept that distal intermediates (e.g., desmosterol) are not merely inert precursors. (skubic2024knockoutsofcyp51a1 pages 8-10)

3) Current applications and real-world implementations

3.1 Therapeutic concept: DHCR24-targeted cholesterol lowering (metabolic disease)

Blocking DHCR24 is being investigated as a cholesterol-lowering approach. In a 2023 study, competitive DHCR24 inhibition by irbesartan was proposed as a repurposing strategy, supported by cell-based cholesterol lowering and an in vitro IC50 of 602 nM. (wang2023virtualscreeningof pages 1-2)

Real-world implementation remains preclinical for DHCR24-selective agents, but the concept intersects with pharmacovigilance: a 2024 review catalogued many chemical exposures and approved drugs that can inhibit post-lanosterol sterol biosynthesis, implying that off-target DHCR24 inhibition may already occur in clinical practice and could be relevant to safety (especially in pregnancy/neurodevelopment). (peeples2024chemicalinhibitionof pages 6-7)

3.2 Neurodegeneration: DHCR24 gene delivery as an experimental AD intervention

In a 2023 Alzheimer’s mouse model study, hippocampal delivery of AAV-DHCR24 in 5xFAD mice increased filipin-detectable cholesterol in hippocampus and was reported to significantly reverse cognitive impairment and multiple AD-related pathological readouts (amyloid-β deposition, synaptic injury markers, glial activation, autophagy, apoptosis). This is a concrete preclinical implementation of DHCR24 modulation as a disease-modifying strategy. (zhang2023dhcr24reversesalzheimer’s pages 1-2, zhang2023dhcr24reversesalzheimer’s pages 14-15)

3.3 Oncology: DHCR24/sterol metabolism as a tumor vulnerability and resistance node

A 2024 melanoma study reported that reducing intracellular cholesterol by DHCR24 knockdown impaired proliferation/migration and reduced xenograft tumor volume, while DHCR24/cholesterol promoted spheroid growth and vemurafenib resistance through a cholesterol-metabolite mechanism involving 27-hydroxycholesterol (27HC) and Rap1–PI3K/AKT signaling. (wang2024cholesterolneutralizedvemurafenib pages 1-2, wang2024cholesterolneutralizedvemurafenib pages 10-13)

4) Expert opinions and authoritative analysis

A 2024 cancer-focused review frames DHCR24 as both a cholesterol-synthesis enzyme and a regulator intersecting with oncogenic signaling (e.g., ROS, p53, Ras, PI3K/AKT) and emphasizes DHCR24’s membrane topology/interaction regions when interpreting non-enzymatic phenotypes; although narrative, it consolidates evidence linking cholesterol pathway flux to tumor progression and therapy response. (fu2024dhcr24intumor pages 1-2, fu2024dhcr24intumor pages 12-13)

A 2024 sterol-inhibition review argues that late-pathway sterol inhibition (including DHCR24) is an underrecognized mechanism by which diverse chemicals and medications can perturb homeostasis, and it highlights knowledge gaps in both mechanisms and long-term consequences—an expert consensus-style warning relevant for translational work. (peeples2024chemicalinhibitionof pages 6-7)

5) Recent statistics and data points (selected)

  1. Irbesartan as a DHCR24 inhibitor (2023): IC50 602 nM against DHCR24 in vitro. (wang2023virtualscreeningof pages 1-2, wang2023virtualscreeningof pages 12-13)
  2. DHCR24→27HC shift in melanoma (2024): 27HC increased from 89.784 ng/mL (control) to 129.240 ng/mL (DHCR24 overexpression) with FC = 1.439 and p = 0.0000751 (n=6 in the study’s table). (wang2024cholesterolneutralizedvemurafenib media 6e0d6af5, wang2024cholesterolneutralizedvemurafenib pages 10-13)
  3. Cell-cycle effect of DHCR24 KO (2024): G0+G1 phase 58% (native) → 63% (DHCR24 KO) in HepG2. (skubic2024knockoutsofcyp51a1 pages 8-10)
  4. Biochemical requirement (2024 genetics paper): desmosterol→cholesterol conversion in vitro is strictly NADPH-dependent and ~2× increased by addition of FAD. (cocciadiferro2024exploitinginsilico pages 1-2)

6) Mechanistic synthesis (functional annotation narrative)

DHCR24 (Q15392) is best annotated as an ER-associated, single-pass membrane FAD-dependent oxidoreductase that performs Δ24(25) sterol double-bond reduction in distal cholesterol biosynthesis, most classically converting desmosterol to cholesterol in the Bloch pathway. (fu2024dhcr24intumor pages 1-2, wang2023virtualscreeningof pages 1-2)

Because DHCR24 sits at a distal branchpoint that shapes sterol intermediate pools, its perturbation can produce pleiotropic effects via (i) cholesterol availability (membrane structure, lipid rafts), and (ii) bioactive intermediates such as desmosterol and oxysterols (e.g., 27HC), which can engage nuclear receptors and signaling pathways. This mechanistic framing is directly supported by recent cell and disease-model studies showing DHCR24-dependent shifts to 27HC with downstream Rap1–PI3K/AKT activation in melanoma, and by sterol-intermediate-driven transcriptional/cell-cycle remodeling in engineered KO systems. (wang2024cholesterolneutralizedvemurafenib pages 10-13, skubic2024knockoutsofcyp51a1 pages 8-10)

  • Fu & Wang. Technology in Cancer Research & Treatment. Published Jan 2024. https://doi.org/10.1177/15330338241259780 (fu2024dhcr24intumor pages 1-2)
  • Peeples et al. Biomolecules. Published Mar 2024. https://doi.org/10.3390/biom14040410 (peeples2024chemicalinhibitionof pages 6-7)
  • Cocciadiferro et al. Frontiers in Genetics. Published 04 Jan 2024. https://doi.org/10.3389/fgene.2023.1307934 (cocciadiferro2024exploitinginsilico pages 1-2)
  • Skubic et al. iScience. Published Sep 2024. https://doi.org/10.1016/j.isci.2024.110651 (skubic2024knockoutsofcyp51a1 pages 8-10)
  • Wang et al. Cellular and Molecular Life Sciences. Accepted 05 May 2024 (published 2024). https://doi.org/10.1007/s00018-024-05267-3 (wang2024cholesterolneutralizedvemurafenib pages 1-2)
  • Zhang et al. Acta Neuropathologica Communications. Accepted 30 May 2023 (published 2023). https://doi.org/10.1186/s40478-023-01593-y (zhang2023dhcr24reversesalzheimer’s pages 1-2)
  • Wang et al. Molecules. Published Mar 2023. https://doi.org/10.3390/molecules28062643 (wang2023virtualscreeningof pages 1-2)
  • Lu et al. Cell and Tissue Research. Published Jul 2023. https://doi.org/10.1007/s00441-023-03804-3 (lu2023highfatdiet pages 9-12)

Figure/Table evidence extracted from visual content

Quantitative 27HC changes upon DHCR24 overexpression are supported by a table and figure panels extracted from Wang et al. 2024 (Table 2; Fig. 3J–K). (wang2024cholesterolneutralizedvemurafenib media 6e0d6af5, wang2024cholesterolneutralizedvemurafenib media ab69483a)

References

  1. (fu2024dhcr24intumor pages 1-2): Xin Fu and Zhaosong Wang. Dhcr24 in tumor diagnosis and treatment: a comprehensive review. Technology in Cancer Research & Treatment, Jan 2024. URL: https://doi.org/10.1177/15330338241259780, doi:10.1177/15330338241259780. This article has 17 citations and is from a peer-reviewed journal.

  2. (wang2023virtualscreeningof pages 12-13): Haozhen Wang, Ziyin Lu, Yang Li, Ting Liu, Linlin Zhao, Tianqi Gao, Xiuli Lu, and Bing Gao. Virtual screening of novel 24-dehydroxysterol reductase (dhcr24) inhibitors and the biological evaluation of irbesartan in cholesterol-lowering effect. Molecules, 28:2643, Mar 2023. URL: https://doi.org/10.3390/molecules28062643, doi:10.3390/molecules28062643. This article has 15 citations.

  3. (fu2024dhcr24intumor pages 12-13): Xin Fu and Zhaosong Wang. Dhcr24 in tumor diagnosis and treatment: a comprehensive review. Technology in Cancer Research & Treatment, Jan 2024. URL: https://doi.org/10.1177/15330338241259780, doi:10.1177/15330338241259780. This article has 17 citations and is from a peer-reviewed journal.

  4. (wang2023virtualscreeningof pages 1-2): Haozhen Wang, Ziyin Lu, Yang Li, Ting Liu, Linlin Zhao, Tianqi Gao, Xiuli Lu, and Bing Gao. Virtual screening of novel 24-dehydroxysterol reductase (dhcr24) inhibitors and the biological evaluation of irbesartan in cholesterol-lowering effect. Molecules, 28:2643, Mar 2023. URL: https://doi.org/10.3390/molecules28062643, doi:10.3390/molecules28062643. This article has 15 citations.

  5. (bai2022theroleof pages 3-5): Xiaojing Bai, Meiting Mai, Kai Yao, MengQi Zhang, Yue Huang, Wenbin Zhang, Xiaorou Guo, Yixuan Xu, Ying Zhang, Atikam Qurban, Lijie Duan, Jimei Bu, Jianfeng Zhang, Junfeng Wu, Yong-fei Zhao, Xiangshan Yuan, and Heng-bing Zu. The role of dhcr24 in the pathogenesis of ad: re-cognition of the relationship between cholesterol and ad pathogenesis. Acta Neuropathologica Communications, Mar 2022. URL: https://doi.org/10.1186/s40478-022-01338-3, doi:10.1186/s40478-022-01338-3. This article has 55 citations and is from a peer-reviewed journal.

  6. (cocciadiferro2024exploitinginsilico pages 1-2): Dario Cocciadiferro, Tommaso Mazza, Davide Vecchio, Tommaso Biagini, Francesco Petrizzelli, Emanuele Agolini, Andrea Villani, Daniele Minervino, Diego Martinelli, Cristiano Rizzo, Sara Boenzi, Filippo Maria Panfili, Paola Sabrina Buonuomo, Marina Macchiaiolo, Andrea Bartuli, and Antonio Novelli. Exploiting in silico structural analysis to introduce emerging genotype–phenotype correlations in dhcr24-related sterol biosynthesis disorder: a case study. Frontiers in Genetics, Jan 2024. URL: https://doi.org/10.3389/fgene.2023.1307934, doi:10.3389/fgene.2023.1307934. This article has 7 citations and is from a peer-reviewed journal.

  7. (skubic2024knockoutsofcyp51a1 pages 8-10): Cene Skubic, Hana Trček, Petra Nassib, Tinkara Kreft, Andrew Walakira, Katka Pohar, Sara Petek, Tadeja Režen, Alojz Ihan, and Damjana Rozman. Knockouts of cyp51a1, dhcr24, or sc5d from cholesterol synthesis reveal pathways modulated by sterol intermediates. iScience, 27:110651, Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110651, doi:10.1016/j.isci.2024.110651. This article has 10 citations and is from a peer-reviewed journal.

  8. (peeples2024chemicalinhibitionof pages 17-18): Eric Peeples, Karoly Mirnics, and Zeljka Korade. Chemical inhibition of sterol biosynthesis. Biomolecules, 14:410, Mar 2024. URL: https://doi.org/10.3390/biom14040410, doi:10.3390/biom14040410. This article has 17 citations.

  9. (zhang2023dhcr24reversesalzheimer’s pages 1-2): Wen-bin Zhang, Yue Huang, Xiao-rou Guo, Meng-qi Zhang, Xiang-shan Yuan, and Heng-bing Zu. Dhcr24 reverses alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xfad mice. Acta Neuropathologica Communications, Jun 2023. URL: https://doi.org/10.1186/s40478-023-01593-y, doi:10.1186/s40478-023-01593-y. This article has 38 citations and is from a peer-reviewed journal.

  10. (zhang2023dhcr24reversesalzheimer’s pages 14-15): Wen-bin Zhang, Yue Huang, Xiao-rou Guo, Meng-qi Zhang, Xiang-shan Yuan, and Heng-bing Zu. Dhcr24 reverses alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xfad mice. Acta Neuropathologica Communications, Jun 2023. URL: https://doi.org/10.1186/s40478-023-01593-y, doi:10.1186/s40478-023-01593-y. This article has 38 citations and is from a peer-reviewed journal.

  11. (wang2024cholesterolneutralizedvemurafenib pages 10-13): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.

  12. (wang2024cholesterolneutralizedvemurafenib media 6e0d6af5): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.

  13. (lu2023highfatdiet pages 9-12): Ziyin Lu, Haozhen Wang, Xiujin Zhang, Xiuting Huang, Shan Jiang, Yang Li, Ting Liu, Xiuli Lu, and Bing Gao. High fat diet induces brain injury and neuronal apoptosis via down-regulating 3-β hydroxycholesterol 24 reductase (dhcr24). Cell and Tissue Research, 393:471-487, Jul 2023. URL: https://doi.org/10.1007/s00441-023-03804-3, doi:10.1007/s00441-023-03804-3. This article has 8 citations and is from a peer-reviewed journal.

  14. (fu2024dhcr24intumor pages 2-3): Xin Fu and Zhaosong Wang. Dhcr24 in tumor diagnosis and treatment: a comprehensive review. Technology in Cancer Research & Treatment, Jan 2024. URL: https://doi.org/10.1177/15330338241259780, doi:10.1177/15330338241259780. This article has 17 citations and is from a peer-reviewed journal.

  15. (skubic2024knockoutsofcyp51a1 pages 10-12): Cene Skubic, Hana Trček, Petra Nassib, Tinkara Kreft, Andrew Walakira, Katka Pohar, Sara Petek, Tadeja Režen, Alojz Ihan, and Damjana Rozman. Knockouts of cyp51a1, dhcr24, or sc5d from cholesterol synthesis reveal pathways modulated by sterol intermediates. iScience, 27:110651, Sep 2024. URL: https://doi.org/10.1016/j.isci.2024.110651, doi:10.1016/j.isci.2024.110651. This article has 10 citations and is from a peer-reviewed journal.

  16. (peeples2024chemicalinhibitionof pages 6-7): Eric Peeples, Karoly Mirnics, and Zeljka Korade. Chemical inhibition of sterol biosynthesis. Biomolecules, 14:410, Mar 2024. URL: https://doi.org/10.3390/biom14040410, doi:10.3390/biom14040410. This article has 17 citations.

  17. (wang2024cholesterolneutralizedvemurafenib pages 1-2): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.

  18. (wang2024cholesterolneutralizedvemurafenib media ab69483a): Xiaohong Wang, Feiliang Zhong, Tingting Chen, Hongbo Wang, Weifang Wang, Hongkai Jin, Chouyang Li, Xuan Guo, Ying Liu, Yu Zhang, and Bo Li. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol. Cellular and Molecular Life Sciences: CMLS, May 2024. URL: https://doi.org/10.1007/s00018-024-05267-3, doi:10.1007/s00018-024-05267-3. This article has 7 citations.

Citations

  1. lu2023highfatdiet pages 9-12
  2. cocciadiferro2024exploitinginsilico pages 1-2
  3. wang2023virtualscreeningof pages 1-2
  4. peeples2024chemicalinhibitionof pages 6-7
  5. wang2024cholesterolneutralizedvemurafenib pages 1-2
  6. wang2023virtualscreeningof pages 12-13
  7. bai2022theroleof pages 3-5
  8. peeples2024chemicalinhibitionof pages 17-18
  9. wang2024cholesterolneutralizedvemurafenib pages 10-13
  10. https://doi.org/10.1177/15330338241259780
  11. https://doi.org/10.3390/biom14040410
  12. https://doi.org/10.3389/fgene.2023.1307934
  13. https://doi.org/10.1016/j.isci.2024.110651
  14. https://doi.org/10.1007/s00018-024-05267-3
  15. https://doi.org/10.1186/s40478-023-01593-y
  16. https://doi.org/10.3390/molecules28062643
  17. https://doi.org/10.1007/s00441-023-03804-3
  18. https://doi.org/10.1177/15330338241259780,
  19. https://doi.org/10.3390/molecules28062643,
  20. https://doi.org/10.1186/s40478-022-01338-3,
  21. https://doi.org/10.3389/fgene.2023.1307934,
  22. https://doi.org/10.1016/j.isci.2024.110651,
  23. https://doi.org/10.3390/biom14040410,
  24. https://doi.org/10.1186/s40478-023-01593-y,
  25. https://doi.org/10.1007/s00018-024-05267-3,
  26. https://doi.org/10.1007/s00441-023-03804-3,

📄 View Raw YAML

id: Q15392
gene_symbol: DHCR24
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: DHCR24 encodes Delta(24)-sterol reductase (also known as seladin-1),
  the terminal enzyme in cholesterol biosynthesis that catalyzes the reduction of
  the delta-24 double bond of sterol intermediates, primarily converting desmosterol
  to cholesterol. The enzyme is FAD-dependent, requires NADPH as a cofactor, and is
  localized to the endoplasmic reticulum membrane. DHCR24 also confers neuroprotection
  against oxidative stress and amyloid-beta toxicity. Mutations in DHCR24 cause desmosterolosis,
  a rare autosomal recessive disorder of cholesterol biosynthesis characterized by
  multiple congenital anomalies and elevated desmosterol levels.
existing_annotations:
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation for cytoplasm is incorrect. DHCR24 is an integral ER membrane
      protein with its catalytic domain oriented toward the cytoplasm [PMID:11007892,
      PMID:22010141]. The cytoplasmic annotation reflects the cytoplasmic orientation
      of the catalytic domain rather than true cytoplasmic localization.
    action: REMOVE
    reason: This annotation incorrectly implies cytoplasmic localization
      when the protein is actually an integral ER membrane protein with a cytoplasmic-facing
      catalytic domain. The UniProt record and experimental evidence clearly establish
      ER membrane as the primary localization [PMID:11007892, PMID:22010141].
    supported_by:
    - reference_id: PMID:22010141
      supporting_text: We showed that full-length DHCR24 is localized to the membrane
        of ER, whereas the predicted transmembrane (TM) domain-deleted DHCR24 mutation
        is localized to the cytoplasm. The change of DHCR24 localization suggests
        that the N-terminal TM domain is essential for the ER membrane targeting of
        DHCR24.
- term:
    id: GO:0008202
    label: steroid metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation for steroid metabolic process is accurate. DHCR24 is a
      key enzyme in cholesterol biosynthesis, which is part of steroid metabolism.
      The annotation is at an appropriate level of specificity given that cholesterol
      is the precursor for all steroid hormones.
    action: ACCEPT
    reason: DHCR24 clearly participates in steroid metabolism through its essential
      role in cholesterol biosynthesis. Cholesterol is both a steroid itself and the
      precursor for all steroid hormones. The IBA annotation is well-supported by
      experimental evidence [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: We identified the human DHCR24 cDNA, by the similarity between
        the encoded protein and a recently characterized plant enzyme—DWF1/DIM, from
        Arabidopsis thaliana —catalyzing a different but partially similar reaction
        in steroid/sterol biosynthesis in plants. Heterologous expression, in the
        yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity
        measurements, confirmed that it encodes DHCR24
- term:
    id: GO:0000246
    label: Delta24(24-1) sterol reductase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation for Delta24(24-1) sterol reductase activity is correct
      and represents a core molecular function. This term specifically describes the
      enzymatic activity of DHCR24 in reducing the delta-24 double bond in sterols,
      which is directly validated by experimental evidence [PMID:11519011].
    action: ACCEPT
    reason: This is the core molecular function of DHCR24, experimentally validated
      through multiple studies. The enzyme specifically catalyzes the reduction of
      the delta-24 double bond in sterol intermediates, including desmosterol, lanosterol,
      and zymosterol [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
        is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
        and is increased twofold by the addition of FAD to the assay
- term:
    id: GO:0050614
    label: Delta24-sterol reductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000003
  review:
    summary: IEA annotation for Delta24-sterol reductase activity based on EC number
      mapping. This is essentially the same function as GO:0000246 but with slightly
      different terminology. Both terms correctly describe the core enzymatic function
      of DHCR24.
    action: ACCEPT
    reason: This annotation accurately describes the enzymatic activity of DHCR24.
      The term is based on EC:1.3.1.72 mapping which is experimentally validated [PMID:11519011].
      This is a duplicate of GO:0000246 with different terminology but both are correct.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
        cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
        of sterol intermediates
- term:
    id: GO:0000139
    label: Golgi membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: IEA annotation for Golgi membrane based on UniProt subcellular location
      vocabulary. DHCR24 is detected in Golgi to a lesser extent than ER, where
      cholesterol synthesis occurs [PMID:11007892].
    action: KEEP_AS_NON_CORE
    reason: Golgi localization occurs to a minor extent and is not the primary
      functionally relevant site. The ER membrane is the established primary location for DHCR24
      function in cholesterol biosynthesis. UniProt notes both localizations but emphasizes
      ER [PMID:11007892].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: subcellular fractionation and enzyme assays... seladin-1 is
        predominantly localized within the ER, and to a lesser amount in Golgi complexes
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: IEA annotation for endoplasmic reticulum membrane is accurate and represents
      the primary cellular localization. This is the established site where DHCR24
      performs its enzymatic function in cholesterol biosynthesis, confirmed by multiple
      experimental studies [PMID:11007892, PMID:22010141].
    action: ACCEPT
    reason: ER membrane is the correct and primary localization for DHCR24. This is
      where the enzyme performs its function in cholesterol biosynthesis. Multiple
      experimental studies confirm this localization [PMID:11007892, PMID:22010141].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: seladin-1 is predominantly localized within the ER, and to
        a lesser amount in Golgi complexes
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation for lipid metabolic process based on UniProt keyword mapping.
      This is accurate but very general. More specific terms like cholesterol biosynthetic
      process (GO:0006695) better describe the function.
    action: ACCEPT
    reason: While accurate, this is a very broad parent term. DHCR24 does participate
      in lipid metabolism through its role in cholesterol biosynthesis. However, more
      specific child terms provide better functional description.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: in cholesterol biosynthesis, catalyzes the reduction of the
        Δ 24 double bond of sterol intermediates
- term:
    id: GO:0006694
    label: steroid biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation for steroid biosynthetic process is accurate. DHCR24 is
      essential for cholesterol biosynthesis, and cholesterol is both a steroid and
      the precursor for all steroid hormones.
    action: ACCEPT
    reason: DHCR24 directly participates in steroid biosynthesis through its essential
      role in producing cholesterol, which is a steroid molecule and the precursor
      for all steroid hormones [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: desmosterolosis is a cholesterol-biosynthesis disorder caused
        by mutations in DHCR24
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation for cholesterol biosynthetic process is accurate and represents
      a core function. DHCR24 is the terminal enzyme in cholesterol biosynthesis,
      converting desmosterol to cholesterol [PMID:11519011].
    action: ACCEPT
    reason: This is a core biological process for DHCR24. The enzyme catalyzes the
      final step in cholesterol biosynthesis, converting desmosterol to cholesterol.
      This is experimentally validated [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
        is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
- term:
    id: GO:0008202
    label: steroid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Duplicate IEA annotation for steroid metabolic process (also annotated
      with IBA evidence). The annotation is accurate as DHCR24 participates in cholesterol/steroid
      metabolism.
    action: ACCEPT
    reason: Duplicate but accurate annotation. DHCR24 participates in steroid metabolism
      through cholesterol biosynthesis. The IBA version of this annotation was already
      accepted.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: cholesterol-biosynthesis disorder caused by mutations in DHCR24
- term:
    id: GO:0008203
    label: cholesterol metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation for cholesterol metabolic process is accurate. DHCR24
      is directly involved in cholesterol metabolism as the terminal enzyme in cholesterol
      biosynthesis.
    action: ACCEPT
    reason: DHCR24 is a key enzyme in cholesterol metabolism, specifically in the
      biosynthetic pathway. The annotation accurately captures this core function
      [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
        cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
        of sterol intermediates
- term:
    id: GO:0016126
    label: sterol biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation for sterol biosynthetic process is accurate. DHCR24 is
      essential for sterol biosynthesis, specifically in the final step of converting
      sterol intermediates to cholesterol.
    action: ACCEPT
    reason: DHCR24 is a key enzyme in sterol biosynthesis, catalyzing the reduction
      of the delta-24 double bond in various sterol intermediates including desmosterol,
      lanosterol, and zymosterol [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: catalyzes the reduction of the Δ 24 double bond of sterol intermediates
- term:
    id: GO:0016491
    label: oxidoreductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation for oxidoreductase activity is accurate but very general.
      DHCR24 is indeed an oxidoreductase, specifically a FAD-dependent oxidoreductase
      that uses NADPH. More specific terms like GO:0016628 provide better functional
      description.
    action: ACCEPT
    reason: DHCR24 is a FAD-dependent oxidoreductase that catalyzes redox reactions
      using NADPH as electron donor. While accurate, more specific child terms better
      describe the function [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: member of a recently defined family of flavin adenine dinucleotide
        (FAD)-dependent oxidoreductases
- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: IEA annotation for FAD binding based on InterPro domain mapping. This
      is accurate as DHCR24 contains a FAD-binding domain and FAD enhances its enzymatic
      activity [PMID:11519011].
    action: ACCEPT
    reason: DHCR24 is a FAD-dependent oxidoreductase with a conserved FAD-binding
      domain. Addition of FAD increases enzymatic activity twofold, suggesting noncovalent
      FAD binding [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
        is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
        and is increased twofold by the addition of FAD to the assay
- term:
    id: GO:0071949
    label: FAD binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Duplicate IEA annotation for FAD binding (same as GO:0050660). The annotation
      is accurate as DHCR24 is a FAD-dependent enzyme.
    action: ACCEPT
    reason: Duplicate of GO:0050660 but accurate. DHCR24 requires FAD as a cofactor
      for its oxidoreductase activity [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: member of a recently defined family of flavin adenine dinucleotide
        (FAD)-dependent oxidoreductases
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:30021884
  review:
    summary: Generic protein binding annotation from a large-scale crosslinking mass
      spectrometry study of intact cell nuclei [PMID:30021884]. The WITH field indicates
      interaction with PGRMC1 (O00264). The DHCR24-PGRMC1 interaction was detected
      by crosslinking mass spectrometry (both are ER membrane proteins involved
      in sterol biology), but the generic protein binding term is uninformative.
    action: REMOVE
    reason: Protein binding without specificity is uninformative per curation guidelines.
      The interaction was detected in a high-throughput crosslinking study and the
      functional significance of the DHCR24-PGRMC1 interaction is not well
      characterized.
    supported_by:
    - reference_id: PMID:30021884
      supporting_text: Here we use crosslinking mass spectrometry (XL-MS) to chart
        the protein-protein interactions in intact human nuclei.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35271311
  review:
    summary: Generic protein binding annotation from OpenCell high-throughput endogenous
      tagging study [PMID:35271311]. The WITH field indicates interaction with PGRMC1
      (O00264). While PGRMC1 is a known sterol-binding ER membrane protein, the
      generic protein binding term is uninformative per curation guidelines.
    action: REMOVE
    reason: Non-specific protein binding annotation from high-throughput study lacks
      functional context. The curation guidelines explicitly state to avoid this vague
      term. A more specific MF term should be used if the interaction is validated.
    supported_by:
    - reference_id: PMID:35271311
      supporting_text: We combined genome engineering, confocal live-cell imaging,
        mass spectrometry, and data science to systematically map the localization
        and interactions of human proteins.
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-191273
  review:
    summary: TAS annotation from Reactome for cholesterol biosynthetic process. This
      is a core function of DHCR24 as the terminal enzyme in cholesterol biosynthesis.
    action: ACCEPT
    reason: DHCR24 is the terminal enzyme in cholesterol biosynthesis. This Reactome
      annotation accurately captures this core biological process [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: desmosterolosis is a cholesterol-biosynthesis disorder caused
        by mutations in DHCR24
- term:
    id: GO:0033489
    label: cholesterol biosynthetic process via desmosterol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6807047
  review:
    summary: TAS annotation from Reactome for cholesterol biosynthesis via desmosterol.
      This is the primary pathway where DHCR24 functions, converting desmosterol to
      cholesterol in the Bloch pathway.
    action: ACCEPT
    reason: This specifically describes the Bloch pathway where DHCR24 catalyzes the
      conversion of desmosterol to cholesterol. This is the primary route and core
      function of DHCR24 [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
        is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
- term:
    id: GO:0033490
    label: cholesterol biosynthetic process via lathosterol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6807062
  review:
    summary: TAS annotation from Reactome for cholesterol biosynthesis via lathosterol
      (Kandutsch-Russell pathway). DHCR24 can act on various sterol intermediates
      including those in this alternate pathway.
    action: ACCEPT
    reason: DHCR24 functions in both the Bloch and Kandutsch-Russell pathways of cholesterol
      biosynthesis. It can reduce the delta-24 double bond in various sterol intermediates
      [PMID:25637936].
    supported_by:
    - reference_id: PMID:25637936
      supporting_text: DHCR24 is positioned not only at the end of the Bloch pathway
        but also at the gateway of the Kandutsch-Russell pathway... able to act on
        any of the intermediates in the Bloch pathway to divert them into the Kandutsch-Russell
        pathway
- term:
    id: GO:0007265
    label: Ras protein signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for Ras signaling transferred from orthologs. While DHCR24/seladin-1
      mediates response to Ras-induced senescence [PMID:15577914], this is a stress
      response function rather than core Ras signaling.
    action: KEEP_AS_NON_CORE
    reason: DHCR24/seladin-1 responds to oncogenic Ras stress but is not a core component
      of Ras signaling. It mediates Ras-induced senescence through p53 interactions
      [PMID:15577914]. This is a secondary, non-core function.
    supported_by:
    - reference_id: PMID:15577914
      supporting_text: Seladin-1 (also known as Dhcr24) as a key mediator of Ras-induced
        senescence. Following oncogenic and oxidative stress, Seladin-1 binds p53
        amino terminus
- term:
    id: GO:0008104
    label: intracellular protein localization
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for intracellular protein localization from ortholog transfer.
      This is vague and lacks supporting evidence for DHCR24 having a role in localizing
      other proteins.
    action: REMOVE
    reason: No evidence that DHCR24 functions in protein localization. This appears
      to be an over-annotation from ortholog transfer without validation. The primary
      function is enzymatic in cholesterol biosynthesis.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
        cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
        of sterol intermediates
- term:
    id: GO:0008285
    label: negative regulation of cell population proliferation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for negative regulation of proliferation. DHCR24/seladin-1
      does mediate Ras-induced senescence and suppresses transformation [PMID:15577914],
      supporting an anti-proliferative role.
    action: KEEP_AS_NON_CORE
    reason: DHCR24/seladin-1 mediates oncogenic stress-induced senescence and suppresses
      cellular transformation [PMID:15577914]. This is a validated but non-core function
      distinct from its primary enzymatic role.
    supported_by:
    - reference_id: PMID:15577914
      supporting_text: Ablation of Seladin-1 causes the bypass of Ras-induced senescence
        in rodent and human fibroblasts, and allows Ras to transform these cells
- term:
    id: GO:0009725
    label: response to hormone
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for response to hormone from ortholog transfer. This is
      too vague without specifying which hormones. Cholesterol biosynthesis is regulated
      by hormones but this annotation lacks specificity.
    action: REMOVE
    reason: Overly broad annotation without supporting evidence for specific hormone
      responses by DHCR24. While cholesterol biosynthesis is hormonally regulated,
      this vague annotation provides no functional insight.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
        cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
        of sterol intermediates
- term:
    id: GO:0009888
    label: tissue development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for tissue development from ortholog transfer. While DHCR24
      mutations cause developmental anomalies in desmosterolosis, this is an indirect
      effect of cholesterol deficiency.
    action: KEEP_AS_NON_CORE
    reason: DHCR24 deficiency causes developmental defects in desmosterolosis patients
      [PMID:11519011], but this is secondary to cholesterol deficiency rather than
      a direct developmental role. Non-core but valid consequence.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
        by multiple congenital anomalies
- term:
    id: GO:0016125
    label: sterol metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for sterol metabolic process is accurate. DHCR24 is directly
      involved in sterol metabolism through its enzymatic activity on various sterol
      intermediates.
    action: ACCEPT
    reason: DHCR24 directly participates in sterol metabolism by catalyzing the reduction
      of the delta-24 double bond in multiple sterol intermediates [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: catalyzes the reduction of the Δ 24 double bond of sterol intermediates
- term:
    id: GO:0030539
    label: male genitalia development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for male genitalia development from ortholog transfer.
      While desmosterolosis can include urogenital anomalies, this is too specific
      and indirect.
    action: REMOVE
    reason: Over-specific developmental annotation. While desmosterolosis includes
      congenital anomalies, singling out male genitalia development is not supported
      as a specific function of DHCR24. This is an indirect effect of cholesterol
      deficiency.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
        by multiple congenital anomalies
- term:
    id: GO:0031639
    label: plasminogen activation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for plasminogen activation from ortholog transfer. No
      evidence supports DHCR24 involvement in plasminogen activation. This is
      an erroneous transfer.
    action: REMOVE
    reason: No evidence linking DHCR24 to plasminogen activation. This is
      an incorrect ortholog transfer. DHCR24 functions in cholesterol biosynthesis,
      not coagulation/fibrinolysis pathways.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
        cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
        of sterol intermediates
- term:
    id: GO:0042987
    label: amyloid precursor protein catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for APP catabolism from ortholog transfer. While DHCR24/seladin-1
      protects against amyloid-beta toxicity [PMID:11007892], it does not directly
      catabolize APP.
    action: REMOVE
    reason: DHCR24/seladin-1 protects against amyloid-beta toxicity but does not catabolize
      APP. The protective effect is through reducing oxidative stress and caspase
      activation, not APP processing [PMID:11007892].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: Functional expression of seladin-1 in human neuroglioma H4
        cells resulted in the inhibition of caspase 3 activation after either Aβ-mediated
        toxicity or oxidative stress and protected the cells from apoptotic cell death
- term:
    id: GO:0043588
    label: skin development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for skin development from ortholog transfer. While cholesterol
      is important for skin barrier function, this is an indirect effect of DHCR24
      enzymatic activity.
    action: KEEP_AS_NON_CORE
    reason: Cholesterol biosynthesis is important for skin development and barrier
      function. DHCR24 deficiency can affect skin, but this is secondary to its enzymatic
      role. Non-core but valid indirect function.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
        by multiple congenital anomalies
- term:
    id: GO:0061024
    label: membrane organization
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for membrane organization from ortholog transfer. While
      cholesterol is crucial for membrane structure, DHCR24 does not directly organize
      membranes.
    action: REMOVE
    reason: DHCR24 produces cholesterol which affects membrane properties, but the
      enzyme itself does not organize membranes. This is an over-interpretation of
      its indirect effects through cholesterol production.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24), which, in
        cholesterol biosynthesis, catalyzes the reduction of the Δ 24 double bond
        of sterol intermediates
- term:
    id: GO:0050614
    label: Delta24-sterol reductase activity
  evidence_type: EXP
  original_reference_id: PMID:11519011
  review:
    summary: Experimental evidence for Delta24-sterol reductase activity from the
      key paper identifying DHCR24. This is the core molecular function, directly
      demonstrated through heterologous expression and enzyme activity measurements.
    action: ACCEPT
    reason: Direct experimental validation of DHCR24 enzymatic activity. The study
      used heterologous expression in yeast followed by enzyme activity measurements
      to confirm Delta24-sterol reductase activity [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Heterologous expression, in the yeast Saccharomyces cerevisiae,
        of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that
        it encodes DHCR24
- term:
    id: GO:0050614
    label: Delta24-sterol reductase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9755937
  review:
    summary: TAS annotation from Reactome for Delta24-sterol reductase activity, specifically
      for lanosterol reduction. This is a validated core molecular function of DHCR24.
    action: ACCEPT
    reason: DHCR24 catalyzes the reduction of the delta-24 double bond in multiple
      sterols including lanosterol. This Reactome annotation correctly captures this
      enzymatic activity [PMID:11519011].
    supported_by:
    - reference_id: file:human/DHCR24/DHCR24-uniprot.txt
      supporting_text: Reaction=lanosterol + NADPH + H(+) = 24,25-dihydrolanosterol
        + NADP(+)
- term:
    id: GO:0000246
    label: Delta24(24-1) sterol reductase activity
  evidence_type: IMP
  original_reference_id: PMID:11519011
  review:
    summary: IMP evidence for Delta24(24-1) sterol reductase activity from mutant
      phenotype analysis. Mutations in DHCR24 cause desmosterolosis with accumulation
      of desmosterol, proving this enzymatic function.
    action: ACCEPT
    reason: Mutations in DHCR24 cause desmosterolosis with elevated desmosterol levels,
      directly demonstrating the enzyme's Delta24-sterol reductase activity through
      mutant phenotype [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Patients with desmosterolosis have elevated levels of the cholesterol
        precursor desmosterol, in plasma, tissue, and cultured cells; this abnormality
        suggests a deficiency of the enzyme 3β-hydroxysterol Δ 24 -reductase (DHCR24)
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: NAS
  original_reference_id: PMID:11007892
  review:
    summary: NAS evidence for ER membrane localization from the seladin-1 paper. Subcellular
      fractionation confirmed predominant ER localization. This is the primary and
      functionally relevant cellular location.
    action: ACCEPT
    reason: Experimental subcellular fractionation demonstrated that seladin-1/DHCR24
      is predominantly localized to the ER membrane, where it performs its enzymatic
      function [PMID:11007892].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: subcellular fractionation and enzyme assays... seladin-1 is
        predominantly localized within the ER, and to a lesser amount in Golgi complexes
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: IMP
  original_reference_id: PMID:11519011
  review:
    summary: IMP evidence for cholesterol biosynthetic process from mutant phenotype.
      DHCR24 mutations cause desmosterolosis with defective cholesterol biosynthesis,
      proving this core function.
    action: ACCEPT
    reason: Mutations in DHCR24 cause desmosterolosis, a cholesterol biosynthesis
      disorder, directly demonstrating the enzyme's essential role in cholesterol
      biosynthesis [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Our data demonstrate that desmosterolosis is a cholesterol-biosynthesis
        disorder caused by mutations in DHCR24
- term:
    id: GO:0033489
    label: cholesterol biosynthetic process via desmosterol
  evidence_type: IMP
  original_reference_id: PMID:11519011
  review:
    summary: IMP evidence for cholesterol biosynthesis via desmosterol pathway. Patients
      with DHCR24 mutations accumulate desmosterol, proving this is the enzyme that
      converts desmosterol to cholesterol.
    action: ACCEPT
    reason: DHCR24 deficiency causes desmosterol accumulation, directly demonstrating
      its role in the desmosterol-to-cholesterol conversion in the Bloch pathway [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Patients with desmosterolosis have elevated levels of the cholesterol
        precursor desmosterol... Conversion of desmosterol to cholesterol by DHCR24
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25637936
  review:
    summary: IPI evidence for protein binding with DHCR7. While this specific DHCR7
      interaction is functionally important, the generic "protein binding" term should
      be avoided per curation guidelines.
    action: REMOVE
    reason: Generic protein binding annotation should be removed even for specific
      interactions. The functionally relevant DHCR7 interaction and its regulatory
      effect on enzyme activity is better captured by more specific functional terms.
    supported_by:
    - reference_id: PMID:25637936
      supporting_text: when the DHCR24 gene is knocked down by siRNA, DHCR7 activity
        is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity,
        but only when a functional form of DHCR24 is used
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-196417
  review:
    summary: TAS annotation from Reactome for ER membrane localization. This is the
      correct primary localization where DHCR24 performs its enzymatic function.
    action: ACCEPT
    reason: ER membrane is the established localization for DHCR24 where it catalyzes
      the conversion of desmosterol to cholesterol [PMID:11007892, PMID:22010141].
    supported_by:
    - reference_id: PMID:22010141
      supporting_text: The membrane topological analysis of 3β-hydroxysteroid-delta24
        reductase (DHCR24) on endoplasmic reticulum
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6807064
  review:
    summary: Another TAS annotation from Reactome for ER membrane. This is a duplicate
      but correct annotation for the primary cellular localization.
    action: ACCEPT
    reason: Duplicate but accurate ER membrane localization annotation from Reactome.
      Multiple evidence sources confirm this localization [PMID:11007892].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: seladin-1 is predominantly localized within the ER
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9755937
  review:
    summary: Another TAS annotation from Reactome for ER membrane. Multiple Reactome
      pathways correctly place DHCR24 at the ER membrane.
    action: ACCEPT
    reason: Another duplicate but accurate ER membrane annotation. The ER is where
      DHCR24 performs its enzymatic function in cholesterol biosynthesis [PMID:11007892].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: seladin-1 is predominantly localized within the ER
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  review:
    summary: HDA evidence for membrane localization from NK cell proteomics study.
      This is very general compared to the specific ER membrane localization established
      by other studies.
    action: ACCEPT
    reason: While less specific than ER membrane annotations, this high-throughput
      data confirms DHCR24 is membrane-associated, consistent with its ER membrane
      localization [PMID:19946888].
    supported_by:
    - reference_id: PMID:19946888
      supporting_text: Defining the membrane proteome of NK cells
- term:
    id: GO:0016628
    label: oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP
      as acceptor
  evidence_type: IDA
  original_reference_id: PMID:11519011
  review:
    summary: IDA evidence for specific oxidoreductase activity. This accurately describes
      DHCR24 mechanism - it reduces C-C double bonds (delta-24) using NADPH as electron
      donor.
    action: ACCEPT
    reason: Direct experimental demonstration that DHCR24 is an oxidoreductase acting
      on CH-CH groups (the delta-24 double bond) with NADPH as acceptor. This is more
      specific than general oxidoreductase activity [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Conversion of desmosterol to cholesterol by DHCR24 in vitro
        is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: ISS annotation for cholesterol biosynthetic process based on sequence
      similarity. This is a duplicate annotation but correctly identifies a core function.
    action: ACCEPT
    reason: Sequence similarity-based annotation that correctly identifies DHCR24
      role in cholesterol biosynthesis. This is validated by experimental evidence
      [PMID:11519011].
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: desmosterolosis is a cholesterol-biosynthesis disorder caused
        by mutations in DHCR24
- term:
    id: GO:0019899
    label: enzyme binding
  evidence_type: IPI
  original_reference_id: PMID:15577914
  review:
    summary: IPI evidence for enzyme binding from the seladin-1 stress response paper.
      DHCR24/seladin-1 binds to Mdm2 (an E3 ubiquitin ligase) to regulate p53. This
      is a non-core stress response function.
    action: KEEP_AS_NON_CORE
    reason: DHCR24/seladin-1 binds the E3 ubiquitin ligase Mdm2 during stress response,
      affecting p53 regulation. This is a validated but non-core function distinct
      from its primary enzymatic role [PMID:15577914].
    supported_by:
    - reference_id: PMID:15577914
      supporting_text: Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin
        ligase Mdm2 from p53... Additionally, Seladin-1 associates with Mdm2 independently
        of p53
- term:
    id: GO:0043588
    label: skin development
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: ISS annotation for skin development based on sequence similarity. While
      cholesterol is important for skin, this is an indirect effect of DHCR24 enzymatic
      function.
    action: KEEP_AS_NON_CORE
    reason: Cholesterol biosynthesis impacts skin development and barrier function.
      DHCR24 deficiency can cause skin abnormalities, but this is secondary to its
      enzymatic role. Non-core indirect function.
    supported_by:
    - reference_id: PMID:11519011
      supporting_text: Desmosterolosis is a rare autosomal recessive disorder characterized
        by multiple congenital anomalies
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:15577914
  review:
    summary: IDA evidence for nuclear localization from stress response study.
      DHCR24/seladin-1 translocates to the nucleus during oncogenic and oxidative
      stress [PMID:15577914], though the primary functional localization is ER membrane.
    action: KEEP_AS_NON_CORE
    reason: DHCR24/seladin-1 can localize to nucleus during stress response to interact
      with p53/Mdm2, but this is not the primary localization. Main function occurs
      at ER membrane [PMID:15577914, PMID:11007892].
    supported_by:
    - reference_id: PMID:15577914
      supporting_text: Following oncogenic and oxidative stress, Seladin-1 binds p53
        amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IDA
  original_reference_id: PMID:11007892
  review:
    summary: IDA evidence for ER localization from the seladin-1 paper. This is the
      correct primary localization, though ER membrane (GO:0005789) is more specific.
    action: ACCEPT
    reason: Direct experimental evidence for ER localization through subcellular fractionation.
      The more specific ER membrane term is also annotated [PMID:11007892].
    supported_by:
    - reference_id: PMID:11007892
      supporting_text: subcellular fractionation and enzyme assays... seladin-1 is
        predominantly localized within the ER
- term:
    id: GO:0009888
    label: tissue development
  evidence_type: IMP
  original_reference_id: PMID:12457401
  review:
    summary: IMP evidence for tissue development from a desmosterolosis case report
      showing developmental delay and anomalies. This is an indirect effect of cholesterol
      deficiency rather than a direct developmental role.
    action: KEEP_AS_NON_CORE
    reason: DHCR24 deficiency causes developmental anomalies in desmosterolosis due
      to cholesterol deficiency. This is an indirect consequence rather than a direct
      developmental function [PMID:12457401].
    supported_by:
    - reference_id: PMID:12457401
      supporting_text: Desmosterolosis presenting with multiple congenital anomalies
        and profound developmental delay
- term:
    id: GO:0042605
    label: peptide antigen binding
  evidence_type: IPI
  original_reference_id: PMID:15577914
  review:
    summary: IPI evidence for peptide antigen binding from the seladin-1 stress response
      study [PMID:15577914]. The WITH field shows UniProtKB:P04637 (p53), indicating
      the annotation was made based on seladin-1 binding the p53 N-terminus.
      However, this interaction is protein-protein binding to p53 during stress
      response, not peptide antigen binding in an immunological sense. The GO term
      peptide antigen binding (GO:0042605) refers to binding of antigenic peptides
      for immune presentation, which does not describe the DHCR24-p53 interaction.
    action: REMOVE
    reason: This is a misannotation. PMID:15577914 describes DHCR24/seladin-1
      binding to the p53 amino terminus during oncogenic and oxidative stress, displacing
      Mdm2. This is a protein-protein interaction, not peptide antigen binding in the
      immunological sense. No MHC or antigen presentation function is described.
    supported_by:
    - reference_id: PMID:15577914
      supporting_text: Following oncogenic and oxidative stress, Seladin-1 binds p53
        amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53, thus
        resulting in p53 accumulation.
core_functions:
- description: Catalyzes the reduction of the delta-24 double bond in sterol intermediates
    using NADPH and FAD as cofactors, converting desmosterol to cholesterol as the
    terminal step of cholesterol biosynthesis
  molecular_function:
    id: GO:0050614
    label: Delta24-sterol reductase activity
  directly_involved_in:
  - id: GO:0006695
    label: cholesterol biosynthetic process
  - id: GO:0033489
    label: cholesterol biosynthetic process via desmosterol
  - id: GO:0033490
    label: cholesterol biosynthetic process via lathosterol
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  substrates:
  - id: CHEBI:17737
    label: desmosterol
  - id: CHEBI:16521
    label: lanosterol
  - id: CHEBI:18252
    label: zymosterol
- description: Positively regulates DHCR7 oxidoreductase activity through direct protein
    interaction, enhancing 7-dehydrocholesterol reductase function in cholesterol
    biosynthesis
  supported_by:
  - reference_id: PMID:25637936
    supporting_text: when the DHCR24 gene is knocked down by siRNA, DHCR7 activity
      is also ablated. Conversely, overexpression of DHCR24 enhances DHCR7 activity
  molecular_function:
    id: GO:0050614
    label: Delta24-sterol reductase activity
  directly_involved_in:
  - id: GO:0006695
    label: cholesterol biosynthetic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000003
  title: Gene Ontology annotation based on Enzyme Commission mapping
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt.
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:11007892
  title: The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's
    disease-associated neurodegeneration and oxidative stress.
  findings: []
- id: PMID:11519011
  title: Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis,
    an autosomal recessive disorder of cholesterol biosynthesis.
  findings: []
- id: PMID:12457401
  title: Desmosterolosis presenting with multiple congenital anomalies and profound
    developmental delay.
  findings: []
- id: PMID:15577914
  title: Regulation of cellular response to oncogenic and oxidative stress by Seladin-1.
  findings: []
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
- id: PMID:25637936
  title: The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact
    physically and functionally.
  findings: []
- id: PMID:30021884
  title: Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry
    in Intact Cell Nuclei.
  findings: []
- id: PMID:35271311
  title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
  findings: []
- id: Reactome:R-HSA-191273
  title: Cholesterol biosynthesis
  findings: []
- id: Reactome:R-HSA-196417
  title: Reduction of desmosterol to cholesterol
  findings: []
- id: Reactome:R-HSA-6807047
  title: Cholesterol biosynthesis via desmosterol
  findings: []
- id: Reactome:R-HSA-6807062
  title: Cholesterol biosynthesis via lathosterol
  findings: []
- id: Reactome:R-HSA-6807064
  title: DHCR24 reduces ZYMOL to ZYMSTNL
  findings: []
- id: Reactome:R-HSA-9755937
  title: DHCR24 reduces LAN to 24,25-dhLAN
  findings: []
suggested_questions:
- question: How does DHCR24 coordinate cholesterol biosynthesis with membrane homeostasis
    and cellular sterol requirements?
- question: What are the regulatory mechanisms that control DHCR24 expression and
    activity in response to sterol levels?
- question: How do mutations in DHCR24 lead to desmosterolosis and what
    are the developmental consequences of altered sterol metabolism?
- question: What determines the subcellular localization of DHCR24 and how does this
    affect its function in sterol metabolism?
suggested_experiments:
- description: Lipidomics analysis to characterize the complete sterol profile in
    DHCR24-deficient cells and tissues
- description: Live-cell imaging using fluorescent sterol analogs to track cholesterol
    metabolism and membrane distribution in real-time
- description: Cryo-EM structure determination of DHCR24 to understand the molecular
    basis of sterol reduction and enzyme specificity
- description: Developmental analysis of DHCR24 mutant model organisms to study the
    role of cholesterol in embryogenesis and organogenesis
status: COMPLETE